Reductions in basal metabolic rate and physical activity contribute to hypothalamic obesity

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 7, 2008, Pages 2588-2593

  Shaikh, M Guftar ^a   Grundy, Richard G ^a,b   Kirk, Jeremy M W ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELEROMETRY; ADOLESCENT; ADULT; ARTICLE; BASAL METABOLIC RATE; CALORIC INTAKE; CALORIMETRY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY EXPENDITURE; FEMALE; HUMAN; HYPOPITUITARISM; HYPOTHALAMIC OBESITY; LEAN BODY WEIGHT; MALE; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL;

EID: 47549114474     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2007-2672     Document Type: Article

References (32)

1. Lustig RH, Rose SR, Burghen GA, Velasquez-Mieyer P, Broome DC, Smith K, Li H, Hudson MM, Heideman RL, Kun LE 1999 Hypothalamic obesity caused by cranial insult in children: altered glucose and insulin dynamics and reversal by a somatostatin agonist. J Pediatr 135(2 Pt 1):162-168
2. Pinkney JH, Daousi C, MacFarlane I 2005 Recent advances in the understanding and treatment of hypothalamic obesity in humans. In: Trends in obesity research. New York, NY: Nova Publishers; 41-66
3. Sahu A 2003 Leptin signaling in the hypothalamus: emphasis on energy homeostasis and leptin resistance. Front Neuroendocrinol 24:225-253
4. Sainsbury A, Cooney GJ, Herzog H 2002 Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab 16:623-637
5. Ruffin M, Nicolaidis S 1999 Electrical stimulation of the ventromedial hypothalamus enhances both fat utilization and metabolic rate that precede and parallel the inhibition of feeding behavior. Brain Res 846:23-29
6. Ruffin M and Nicolaidis S 2000 Intracerebroventricular injection of murine leptin enhances the postprandial metabolic rate in the rat. Brain Res 874:30-36
7. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH 2000 Establishing a standard definition for childhood overweight and obesity worldwide: international survey. BMJ 320:1240
8. Crabtree NJ, Oldroyd B, Truscott JG, Fordham JN, Kibirige M, Fewtrell M, Gordon I, Shaw NJ 2004 UK paediatric reference data (GE Lunar Prodigy): effects of ethnicity, gender and pubertal status. Osteoporos Int S6:15
9. Food Standards Agency and Institute of Food Research 2002 McCance and Widdowson's the Composition of Foods. 6th ed. Cambridge, UK: Royal Society of Chemistry
10. Department of Health 1991 Dietary reference values for the UK. Report on the dietary reference values of the Committee on Medical Aspects of Food Policy. London: HMSO
11. Bray GA and Gallagher Jr TF 1975 Manifestations of hypothalamic obesity in man: a comprehensive investigation of eight patients and a review of the literature. Medicine (Baltimore) 54:301-330
12. Goran MI, Treuth MS 2001 Energy expenditure, physical activity, and obesity in children. Pediatr Clin North Am 48:931-953
13. Welle S, Schwartz RG, Statt M 1991 Reduced metabolic rate during -adrenergic blockade in humans. Metabolism 40:619-622
14. Silvestri E, Schiavo L, Lombardi A, Goglia F 2005 Thyroid hormones as molecular determinants of thermogenesis. Acta Physiol Scand 184:265-283
15. Onur S, Haas V, Bosy-Westphal A, Hauer M, Paul T, Nutzinger D, Klein H, Muller MJ 2005 L-Tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 152:179-184
16. Mark AL, Rahmouni K, Correia M, Haynes WG 2003 A leptin-sympatheticleptin feedback loop: potential implications for regulation of arterial pressure and body fat. Acta Physiol Scand 177:345-349
17. Lustig RH, Hinds PS, Ringwald-Smith K, Christensen RK, Kaste SC, Schreiber RE, Rai SN, Lensing SY, Wu S, Xiong X 2003 Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial. J Clin Endocrinol Metab 88:2586-2592
18. Cettour-Rose P, Burger AG, Meier CA, Visser TJ, Rohner-Jeanrenaud F 2002 Central stimulatory effect of leptin on T3 production is mediated by brown adipose tissue type II deiodinase. Am J Physiol Endocrinol Metab 283:E980-E987
19. Sullo A, Brizzi G, Maffulli N 2004 Triiodothyronine deiodinating activity in brown adipose tissue after short cold stimulation test in trained and untrained rats. Physiol Res 53:69-76
20. Fernandes JK, Klein MJ, Ater JL, Kuttesch JF, Vassilopoulou-Sellin R 2002 Triiodothyronine supplementation for hypothalamic obesity. Metabolism 51:1381-1383
21. Mason PW, Krawiecki N, Meacham LR 2002 The use of dextroamphetamine to treat obesity and hyperphagia in children treated for craniopharyngioma. Arch Pediatr Adolesc Med 156:887-892
22. Harz KJ, Muller HL, Waldeck E, Pudel V, Roth C 2003Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity. J Clin Endocrinol Metab 88:5227-5231
23. Warner JT, Bell W, Webb DK, Gregory JW 1998 Daily energy expenditure and physical activity in survivors of childhood malignancy. Pediatr Res 43:607-613
24. Poretti A, Grotzer MA, Ribi K, Schonle E, Boltshauser E 2004 Outcome of craniopharyngioma in children: long-term complications and quality of life. Dev Med Child Neurol 46:220-229
25. Muller HL, Handwerker G, Wollny B, Faldum A, Sorensen N 2002 Melatonin secretion and increased daytime sleepiness in childhood craniopharyngioma patients. J Clin Endocrinol Metab 87:3993-3996
26. Taheri, S 2006 The link between short sleep duration and obesity: we should recommend more sleep to prevent obesity. Arch Dis Child 91:881-884
27. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E 2005 Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 99:2008-2019
28. Pinkney J, Wilding J, Williams G, MacFarlane I 2002 Hypothalamic obesity in humans: what do we know and what can be done? Obes Rev 3:27-34
29. Roth C, Wilken B, Hanefeld F, Schroter W, Leonhardt U 1998 Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 138:89-91
30. Skorzewska A, Lal S, Waserman J, Guyda H 1989 Abnormal food-seeking behavior after surgery for craniopharyngioma. Neuropsychobiology 21:17-20
31. Jordaan GP, Roberts MC, Emsley RA 1996 Serotonergic agents in the treatment of hypothalamic obesity syndrome: a case report. Int J Eat Disord 20:111-113
32. Marcus Claude, Norgen S, Danielsson P 2005 Sibutramine treatment of children with hypothalamic obesity and other aggravating syndromes. Horm Res 64(Suppl 1):269